Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience
Journal of Nephrology · 20.08.2024 · 37 (8) · 2059-2060
DOI: 10.1007/s40620-024-02057-9 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Nephrology, online erschienen am 20.08.2024. Verfasst von Frank Rutsch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics and Center for Rare Diseases, Muenster University Children's Hospital, Muenster, Germany. frank.rutsch@ukmuenster.de. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Münster.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of General Pediatrics and Center for Rare Diseases, Muenster University Children's Hospital, Muenster, Germany. frank.rutsch@ukmuenster.de.
- Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
- Metabolic Medicine Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Förderung
- Universitätsklinikum Münster
Zitieren
APA
Rutsch, F., Salusky, I. B., & Ferreira, C. R. (2024). Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience. Journal of Nephrology, 37(8), 2059-2060. https://doi.org/10.1007/s40620-024-02057-9
Vancouver
Rutsch F, Salusky IB, Ferreira CR. Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience. Journal of Nephrology. 2024;37(8):2059-2060. doi:10.1007/s40620-024-02057-9
BibTeX
@article{Rutsch2024,
author = {Rutsch, Frank and Salusky, Isidro B and Ferreira, Carlos R},
title = {Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience},
journal = {Journal of Nephrology},
year = {2024},
volume = {37},
number = {8},
pages = {2059--2060},
doi = {10.1007/s40620-024-02057-9}
}
EUVIMED